The purpose of this tool is to allow cancer services to review the uptake of clinical governance roles and responsibilities by their medical oncologists, haematologists, nurses, pharmacists and managers working in its cancer care areas.
This document summarises medicines being investigated to treat COVID-19. Medicines where there is emerging evidence against COVID-19 are described. There is a lack of robust evidence on specific treatment options for COVID-19 and any proposed therapies are considered experimental at this stage.
In Australia and across the global community, organisations have gathered evidence and/or developed advice on the management of COVID-19. A list of links to COVID-19 guidance is presented here and will be updated regularly. This list is prepared to support the delivery of safe and quality care during the COVID-19 pandemic and is not an endorsement by the Australian Commission on Safety and Quality in Health Care.